Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Michiel Koeijvoets"'
Autor:
Jennifer Fable, Michiel Koeijvoets, G. Kees Hovingh, Yale B. Mitchel, Sukrut Shah, Amy O. Johnson-Levonas, Jean Bergeron, Naab Al-Saady, John J.P. Kastelein, Gisle Langslet, Aditi Sapre, Joost Besseling, John Hunter
Publikováno v:
Lancet, 385(9983), 2153-2161. Elsevier Limited
Present guidelines emphasise the importance of low concentrations of LDL cholesterol (LDL-C) in patients with familial hypercholesterolaemia. In most patients with the disease, however, these concentrations are not achieved with present treatments, s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d106347dfa1330a984263e6f41a3ca
https://pure.amc.nl/en/publications/anacetrapib-as-lipidmodifying-therapy-in-patients-with-heterozygous-familial-hypercholesterolaemia-realize-a-randomised-doubleblind-placebocontrolled-phase-3-study(f0a930ee-34e5-4054-aba1-76b6963141e0).html
https://pure.amc.nl/en/publications/anacetrapib-as-lipidmodifying-therapy-in-patients-with-heterozygous-familial-hypercholesterolaemia-realize-a-randomised-doubleblind-placebocontrolled-phase-3-study(f0a930ee-34e5-4054-aba1-76b6963141e0).html
Autor:
Yale B. Mitchel, Naab Al-Saady, Aditi Sapre, Sukrut Shah, Jennifer Fable, John J.P. Kastelein, Jean Bergeron, Michiel Koeijvoets, Amy O. Johnson-Levonas, G. Kees Hovingh, John Hunter, Joost Besseling, G. Langslet
Publikováno v:
Circulation. 130
Introduction: Anacetrapib, a cholesteryl ester transfer protein inhibitor, has been shown to robustly reduce atherogenic lipoproteins including low-density lipoprotein cholesterol (LDL-C), Apo B and raise high-density lipoprotein cholesterol (HDL-C)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::98b20dc9c2c42bb27accb266473cb577
https://doi.org/10.1161/circ.130.suppl_2.9613
https://doi.org/10.1161/circ.130.suppl_2.9613
